Distinguishing normal brain aging from the development of Alzheimer's disease: inflammation, insulin signaling and cognition

by Paul Denver, Paula L McClean
Published 2018-01-01

Early Stage Glycosylation Biomarkers in Alzheimer’s Disease

by Patricia Regan, Paula L. McClean, Thomas Smyth, Margaret Doherty
Published 2019-09-01

Multi‐time‐point data preparation robustly reveals MCI and dementia risk factors

by Daman Kaur, Magda Bucholc, David P. Finn, Stephen Todd, KongFatt Wong‐Lin, Paula L. McClean
Published 2020-01-01

Correction: A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe/PS1ΔE9 Mouse Model of Alzheimer...

by Vadivel Parthsarathy, Paula L. McClean, Christian Hölscher, Mark Taylor, Claire Tinker, Glynn Jones, Oleg Kolosov, Elisa Salvati, Maria Gregori, Massimo Masserini, David Allsop
Published 2013-01-01

A novel retro-inverso peptide inhibitor reduces amyloid deposition, oxidation and inflammation and stimulates neurogenesis in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease.

by Vadivel Parthsarathy, Paula L McClean, Christian Hölscher, Mark Taylor, Claire Tinker, Glynn Jones, Oleg Kolosov, Elisa Salvati, Maria Gregori, Massimo Masserini, David Allsop
Published 2013-01-01

Correction: A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe/PS1ΔE9 Mouse Model of Alzheimer...

by Vadivel Parthsarathy, Paula L. McClean, Christian Hölscher, Mark Taylor, Claire Tinker, Glynn Jones, Oleg Kolosov, Elisa Salvati, Maria Gregori, Massimo Masserini, David Allsop
Published 2013-01-01

Shaping a data-driven era in dementia care pathway through computational neurology approaches

by KongFatt Wong-Lin, Paula L. McClean, Niamh McCombe, Daman Kaur, Jose M. Sanchez-Bornot, Paddy Gillespie, Stephen Todd, David P. Finn, Alok Joshi, Joseph Kane, Bernadette McGuinness
Published 2020-12-01